These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 28289191)

  • 1. Cathepsin S is the major activator of the psoriasis-associated proinflammatory cytokine IL-36γ.
    Ainscough JS; Macleod T; McGonagle D; Brakefield R; Baron JM; Alase A; Wittmann M; Stacey M
    Proc Natl Acad Sci U S A; 2017 Mar; 114(13):E2748-E2757. PubMed ID: 28289191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-36γ sustains a proinflammatory self-amplifying loop with IL-17C in anti-TNF-induced psoriasiform skin lesions of patients with Crohn's disease.
    Friedrich M; Tillack C; Wollenberg A; Schauber J; Brand S
    Inflamm Bowel Dis; 2014 Nov; 20(11):1891-901. PubMed ID: 25299544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathepsin G cleaves and activates IL-36γ and promotes the inflammation of psoriasis.
    Guo J; Tu J; Hu Y; Song G; Yin Z
    Drug Des Devel Ther; 2019; 13():581-588. PubMed ID: 30804664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil-Derived Proteases Escalate Inflammation through Activation of IL-36 Family Cytokines.
    Henry CM; Sullivan GP; Clancy DM; Afonina IS; Kulms D; Martin SJ
    Cell Rep; 2016 Feb; 14(4):708-722. PubMed ID: 26776523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin (IL)-17/IL-36 axis participates to the crosstalk between endothelial cells and keratinocytes during inflammatory skin responses.
    Mercurio L; Failla CM; Capriotti L; Scarponi C; Facchiano F; Morelli M; Rossi S; Pagnanelli G; Albanesi C; Cavani A; Madonna S
    PLoS One; 2020; 15(4):e0222969. PubMed ID: 32352958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of interleukin 36γ and its cleaver cathepsin G following treatment with narrow-band ultraviolet B phototherapy in psoriasis vulgaris.
    El-Kalioby M; El-Komy MHM; Said ER; Amer MA; Saadi DG; Nouredin Mohammed F; Rashed LA; El Desouky ED; AlOrbani AM
    J Dermatolog Treat; 2022 Jun; 33(4):2358-2363. PubMed ID: 34376113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-17A synergistically enhances TLR3-mediated IL-36γ production by keratinocytes: A potential role in injury-amplified psoriatic inflammation.
    Liu S; Wu F; Wu Z; Li Y; Zhang S; Yu N
    Exp Dermatol; 2019 Mar; 28(3):233-239. PubMed ID: 30614571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-36γ inhibits differentiation and induces inflammation of keratinocyte via Wnt signaling pathway in psoriasis.
    Wang W; Yu X; Wu C; Jin H
    Int J Med Sci; 2017; 14(10):1002-1007. PubMed ID: 28924372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-36γ Is a Strong Inducer of IL-23 in Psoriatic Cells and Activates Angiogenesis.
    Bridgewood C; Fearnley GW; Berekmeri A; Laws P; Macleod T; Ponnambalam S; Stacey M; Graham A; Wittmann M
    Front Immunol; 2018; 9():200. PubMed ID: 29535706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alarmin function of cathelicidin antimicrobial peptide LL37 through IL-36γ induction in human epidermal keratinocytes.
    Li N; Yamasaki K; Saito R; Fukushi-Takahashi S; Shimada-Omori R; Asano M; Aiba S
    J Immunol; 2014 Nov; 193(10):5140-8. PubMed ID: 25305315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Proinflammatory Cytokine IL-36γ Is a Global Discriminator of Harmless Microbes and Invasive Pathogens within Epithelial Tissues.
    Macleod T; Ainscough JS; Hesse C; Konzok S; Braun A; Buhl AL; Wenzel J; Bowyer P; Terao Y; Herrick S; Wittmann M; Stacey M
    Cell Rep; 2020 Dec; 33(11):108515. PubMed ID: 33326792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-36γ (IL-1F9) is a biomarker for psoriasis skin lesions.
    D'Erme AM; Wilsmann-Theis D; Wagenpfeil J; Hölzel M; Ferring-Schmitt S; Sternberg S; Wittmann M; Peters B; Bosio A; Bieber T; Wenzel J
    J Invest Dermatol; 2015 Apr; 135(4):1025-1032. PubMed ID: 25525775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressing IL-36-driven inflammation using peptide pseudosubstrates for neutrophil proteases.
    Sullivan GP; Henry CM; Clancy DM; Mametnabiev T; Belotcerkovskaya E; Davidovich P; Sura-Trueba S; Garabadzhiu AV; Martin SJ
    Cell Death Dis; 2018 Mar; 9(3):378. PubMed ID: 29515113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The psoriasis-associated IL-17A induces and cooperates with IL-36 cytokines to control keratinocyte differentiation and function.
    Pfaff CM; Marquardt Y; Fietkau K; Baron JM; Lüscher B
    Sci Rep; 2017 Nov; 7(1):15631. PubMed ID: 29142248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin (IL)-8 and IL-36γ but not IL-36Ra are related to acrosyringia in pustule formation associated with palmoplantar pustulosis.
    Xiaoling Y; Chao W; Wenming W; Feng L; Hongzhong J
    Clin Exp Dermatol; 2019 Jan; 44(1):52-57. PubMed ID: 29896852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of IL-36γ and its regulation in eosinophilic inflammation in allergic rhinitis.
    Qin X; Liu M; Zhang S; Wang C; Zhang T
    Cytokine; 2019 May; 117():84-90. PubMed ID: 30831444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small Molecule IL-36γ Antagonist as a Novel Therapeutic Approach for Plaque Psoriasis.
    Todorović V; Su Z; Putman CB; Kakavas SJ; Salte KM; McDonald HA; Wetter JB; Paulsboe SE; Sun Q; Gerstein CE; Medina L; Sielaff B; Sadhukhan R; Stockmann H; Richardson PL; Qiu W; Argiriadi MA; Henry RF; Herold JM; Shotwell JB; McGaraughty SP; Honore P; Gopalakrishnan SM; Sun CC; Scott VE
    Sci Rep; 2019 Jun; 9(1):9089. PubMed ID: 31235749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-36γ Induced by the TLR3-SLUG-VDR Axis Promotes Wound Healing via REG3A.
    Jiang Z; Liu Y; Li C; Chang L; Wang W; Wang Z; Gao X; Ryffel B; Wu Y; Lai Y
    J Invest Dermatol; 2017 Dec; 137(12):2620-2629. PubMed ID: 28774595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of small-molecule elastase inhibitors as antagonists of IL-36 cytokine activation.
    Sullivan GP; Davidovich PB; Sura-Trueba S; Belotcerkovskaya E; Henry CM; Clancy DM; Zinoveva A; Mametnabiev T; Garabadzhiu AV; Martin SJ
    FEBS Open Bio; 2018 May; 8(5):751-763. PubMed ID: 29744290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the Peptidoglycan Amidase PGLYRP2 in Epithelial Cells by Interleukin-36γ.
    Scholz GM; Heath JE; Aw J; Reynolds EC
    Infect Immun; 2018 Sep; 86(9):. PubMed ID: 29914927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.